Should You Apply for NIH SBIR/STTR Funding? A Readiness Checklist for Life Science Founders
Being eligible for NIH SBIR/STTR funding does not automatically mean your company is ready to apply. Before committing time and resources, assess whether your project fits an available funding opportunity, whether your evidence supports the proposed work, and whether your team can execute a focused research plan.
For life science founders, the goal is not simply to submit an application. It is to make a sound funding decision.
This checklist helps you work toward one of three outcomes: begin application development, strengthen the project first, or reconsider the funding fit.
1. Confirm eligibility before developing the proposal
NIH SBIR and STTR applicants must meet the applicable U.S. small-business requirements, including rules governing business structure, ownership, control, and size. The size limit is 500 employees, including affiliates. Companies with complex ownership or investment arrangements should review the requirements carefully rather than assume they qualify.
The programs also differ in how research responsibilities are organized. STTR requires a formal partnership with a research institution, with at least 40% of the work performed by the small business and at least 30% by the research institution. SBIR has different work-allocation and principal-investigator employment requirements.
Before moving forward, confirm:
Your company’s ownership and affiliate structure.
The principal investigator’s employment arrangements.
Which organization will perform each part of the research.
Whether those arrangements satisfy the selected program’s requirements.
Eligibility is the first gate. Once it is resolved, the next question is whether the funding opportunity fits your project.
2. Establish NIH fit—not just scientific promise
A promising technology is not, by itself, a complete funding strategy.
Identify the NIH Institute or Center whose mission aligns with your project, then examine the scope and requirements of the specific funding opportunity. Blue Haven’s project-evaluation approach includes assessing Institute or Center alignment and seeking early program-officer feedback.
As an internal planning exercise, write a brief explanation of:
The health-related problem your technology addresses.
The intended users or patient population.
How the proposed research relates to the opportunity.
Why this funding pathway makes sense for your current development stage.
If that explanation remains broad or uncertain, clarify the fit before investing heavily in a full proposal.
Program-officer input can help inform that discussion, but it should not be treated as a promise of funding.
3. Match the funding pathway to your evidence
NIH offers several small-business application pathways. Phase I focuses on feasibility, technical merit, and commercial potential. Fast-Track combines Phase I and Phase II in a single application. Direct to Phase II allows eligible SBIR applicants to bypass Phase I when feasibility has already been demonstrated, subject to the applicable opportunity’s requirements.
The strategic question is not which pathway offers the largest award. It is which pathway your evidence can support.
Ask:
What have we demonstrated already?
What remains uncertain?
Which results support the proposed next step?
Are we trying to establish feasibility or build on feasibility already demonstrated?
For example, a diagnostic company with encouraging early laboratory results may still need to establish whether its approach performs reliably under relevant conditions. A company with a more developed evidence base may be ready to evaluate a later-stage pathway.
These are illustrative planning scenarios, not eligibility determinations. The appropriate choice depends on the evidence and the specific funding opportunity.
4. Define a focused project with measurable milestones
Your company’s long-term vision and your proposed grant project are not the same thing.
A readiness review should isolate the work you want this application to support. As a practical exercise, summarize the project on one page:
The central technical question.
The proposed experiments or development activities.
The evidence supporting the approach.
The milestones that will define success.
The next development decision those results will enable.
Consider the difference between these two planning statements:
“We will develop our diagnostic platform.”
“We will evaluate whether our diagnostic platform meets predefined performance thresholds in a specified sample set.”
The second statement gives the team a clearer basis for discussing study design, resources, and success criteria. It is an illustration of project focus—not a substitute for a complete research plan.
If your team cannot agree on the core question or the milestones, resolve those differences before expanding the proposal.
5. Connect the science to a commercial opportunity
NIH’s small-business programs consider commercial potential alongside scientific and technical merit. Readiness therefore involves more than showing that a technology is interesting or technically plausible.
Use your planning process to examine:
Who would use, purchase, or adopt the product.
What unmet need it addresses.
Which alternatives exist.
What evidence supports its proposed advantage.
What barriers remain between research success and product adoption.
For life science companies, those barriers may include regulatory strategy, manufacturing, clinical validation, reimbursement, or integration into existing workflows.
You do not need to pretend every uncertainty has been resolved. Instead, distinguish what you know from what you still need to learn, and explain how the proposed research advances the product’s development.
6. Test whether your team can execute
A clear proposal concept still needs a workable operating plan.
Identify who will perform each activity, which resources are available, and what depends on outside collaborators. Check that those arrangements align with the selected SBIR or STTR program’s work-allocation requirements.
As an internal readiness check, ask:
Are scientific and administrative responsibilities assigned?
Are essential collaborators committed?
Are facilities, samples, equipment, and other resources available?
Does the budget reflect the work being proposed?
Could any unresolved dependency delay a key milestone?
Treat unanswered questions as planning tasks—not details to address after the narrative is written.
7. Build the timeline around readiness
Start with the applicable funding opportunity’s due date, then work backward through the scientific, financial, and administrative tasks required for submission.
Your internal schedule should leave room for:
Scientific review and revision.
Collaborator input and supporting documents.
Budget development and reconciliation.
Registration and administrative checks.
Final submission review.
A deadline can organize the work. It should not replace the decision about whether the project is ready.
Apply now, strengthen first, or reconsider fit?
Use the checklist to identify the next appropriate action.
DecisionIllustrative situationPractical next stepBegin application developmentEligibility and opportunity fit are clear; the evidence supports the pathway; the project and team are well defined.Establish a proposal-development schedule and resolve remaining application details.Strengthen the project firstThe opportunity fits, but a critical evidence gap, collaborator commitment, or milestone remains unresolved.Create a focused readiness plan with owners and completion dates.Reconsider the funding fitNIH alignment is unclear, the opportunity does not support the proposed work, or eligibility remains uncertain.Resolve those issues before committing to a full application.
This framework is a planning tool, not an NIH scoring system or a prediction of funding success.
Waiting can be a deliberate decision when it allows you to strengthen evidence or clarify the project. Moving forward can also be appropriate when the foundation is in place and the opportunity fits.
The objective is to choose the next step your project can support.
Discuss your project with Blue Haven
Blue Haven Grant Consultants’ project-evaluation process helps teams examine their ideas, NIH alignment, and application strategy before proposal development.
If you are considering NIH SBIR/STTR funding, contact Blue Haven to discuss your project’s readiness and the questions to resolve before you begin.